RecruitingNot ApplicableNCT04674267

Resilience and Equity in Aging, Cancer, and Health (REACH)

Resilience and Equity in Aging, Cancer, and Health (REACH): Promoting Physical Resilience and Cancer Care Equity for Adults Age 70 and Older Diagnosed With Gastrointestinal Malignancy


Sponsor

Dana-Farber Cancer Institute

Enrollment

257 participants

Start Date

Jan 18, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies.


Eligibility

Min Age: 70 Years

Inclusion Criteria4

  • Patients who are age 70+ at time of initial consult at DF/BWCC
  • Diagnosed with a gastrointestinal cancer, including: cancers of the esophagus, stomach, pancreas, liver, bile duct, ampulla, colon, rectum, or anus, as well as neuroendocrine tumors.
  • Continuing care at DF/BWCC beyond initial consult visit
  • English and Spanish-speaking

Exclusion Criteria5

  • Patients less than age 70 at time of initial consultation appointment with DF/BWCC.
  • Patients who are not continuing care at DF/BWCC beyond first consult visit.
  • Not proficient in English or Spanish
  • Patient who are not considered appropriate for enrollment due to complex medical, social, or other situation as determined by their primary oncology team.
  • Participants with psychiatric illness/social situations that would limit compliance with study requirements.

Interventions

OTHERPhase 2 Intervention - Geriatric Co-Management

Participants will complete an electronic fitness assessment questionnaire - once completed, they will receive a score of "Robust", "Pre-Frail" or "Frail". Those who are "Pre-frail" or "Frail" will be randomized to meet with a study geriatrician for geriatric co-management in addition to usual oncology care. All participants will be followed for a duration of 1 year.


Locations(1)

Dana-Farber Cancer Institute

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04674267


Related Trials